GMMMG Consultations

On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below.

Due to the COVID-19 outbreak all active GMMMG consultations were temporarily suspended in April. The active consultations have now been re-opened; please see below for the new end dates. Every effort has been made to allow sufficient time for appropriate clinical input to these documents, but if you foresee any problems or have any questions please email nuth.enquires.gmmmg@nhs.net

Title

Information

Feedback

End date

95

GMMMG Medicines and Guidelines Subgroup - Polypharmacy Resource Pack

On behalf of the GMMMG Medicines and Guidelines Subgroup a Polypharmacy Resource Pack is in development. We now seek comments on this draft. Comments are particularly welcomed in relation to the appendices and suggested SMR templates.  This consultation period is open until 5pm Wednesday 14th October 2020.

Feedback Form

5pm Wednesday
14th October 2020

94

GMMMG Clinical Reference Group
Review of specialist initiation drugs

On behalf of the GMMMG Clinical Reference Group, a review of specialist initiation drugs is underway. We now seek comments on updated recommendations for some GREEN specialist initiation drugs.  Comments are particularly welcomed from primary care- especially in regards to any anticipated impact.   This consultation period is open until 5pm Wednesday 7th October 2020.

Feedback Form

5pm Wednesday
7th October 2020